HORGAN KEVIN 4
4 · SOLIGENIX, INC. · Filed Dec 2, 2011
Insider Transaction Report
Form 4
SOLIGENIX, INC.SNGX
HORGAN KEVIN
Senior VP; Chief Med Officer
Transactions
- Award
Stock Option (Right to Buy)
2011-12-01+1,200,000→ 1,200,000 totalExercise: $0.03From: 2011-12-01Exp: 2021-11-30→ Common Stock (1,200,000 underlying)
Footnotes (1)
- [F1]The option vests immediately as to 300,000 shares and vests as to the remainder of the shares on each three (3) month anniversary of December 1, 2011 at a rate of 75,000 shares per quarter thereafter. The exercise price of the option equals $0.032 per share, the market price of the Company's common stock as of the close of business on December 1, 2011.